Clinical Innovation Leader for Early Assets, Device and Digital in Obesity

Are you ready to shape the next era of obesity and cardiometabolic care?

At Novo Nordisk, we’re looking for a strategic clinical leader to guide early-stage clinical development and ensure drug, device, and digital innovation are integrated into programmes that deliver meaningful, differentiated outcomes for people living with chronic disease.

Your new role

Reporting to the Vice President, Obesity and Cardiometabolic Health, you will lead early clinical innovation as a Senior Director within the area’s leadership team. You will partner with global stakeholders and build trusted relationships with investigators, Key Opinion Leaders (KOLs), and health authorities. You will be accountable for early development strategy and execution readiness for obesity assets, with a primary focus on FIH and Phase 2. You will ensure scientifically robust, strategically differentiated programmes that generate the evidence needed for confident advancement into late-stage develo...